SUPN
Supernus Pharmaceuticals, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum-inputs (vergelijkbare managers):
breedte van houders -5.3% ·
aandelenstroom +10.5% ·
netto nieuwe posities -11.1%
· formule
Geconcentreerde accumulatie: stijgende aandelen bij minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 101 | +2 | 42.40M | $1.97B | +5 | −5 |
| Q1 2026 | 104 | -3 | 41.20M | $2.13B | +5 | −9 |
| Q4 2025 | 107 | 0 | 43.16M | $2.15B | +1 | n/a |
| Q3 2025 | 18 | -1 | 27.64M | $1.32B | n/a | −2 |
| Q2 2025 | 17 | 0 | 22.78M | $717.88M | n/a | n/a |
| Q1 2025 | 14 | 0 | 6.75M | $221.22M | n/a | n/a |
| Q4 2024 | 14 | 0 | 6.49M | $234.56M | +1 | −1 |
| Q3 2024 | 13 | 0 | 4.54M | $141.67M | +1 | −1 |
| Q2 2024 | 13 | n/a | 4.27M | $114.18M | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 8.70M | -7.2% | $415.70M | 0.0% | ▼ Trim | 2 | SEC ↗ ×16 |
| 2 | The Vanguard Group ✦ (passief) | 6.04M | -2.6% | $288.88M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (passief) | 2.19M | -0.9% | $104.54M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | Point72 Asset Management ✦ | 1.76M | +246.9% | $84.18M | 0.2% | ▲ Add | 4 | SEC ↗ |
| 5 | Renaissance Technologies ✦ | 1.74M | +5.2% | $83.18M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 1.42M | +709.0% | $67.71M | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Geode Capital Management ✦ (passief) | 1.41M | +0.7% | $67.39M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 8 | Goldman Sachs Group ✦ | 1.16M | n/a | $55.58M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 9 | D. E. Shaw & Co. ✦ | 979.60K | +63.6% | $46.82M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 10 | Morgan Stanley ✦ | 755.32K | n/a | $36.10M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 11 | Millennium Management ✦ | 346.29K | +2548.9% | $16.55M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 12 | JPMorgan Chase ✦ | 342.57K | n/a | $16.37M | 0.0% | n/c | 1 | SEC ↗ ×14 |
| 13 | Two Sigma Investments ✦ | 257.98K | +350.2% | $12.33M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 14 | Arrowstreet Capital ✦ | 226.41K | -8.7% | $10.82M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 136.43K | -2.9% | $6.52M | 0.0% | ▼ Trim | 6 | SEC ↗ ×5 |
| 16 | Fidelity (FMR) ✦ | 100.44K | +24.2% | $4.80M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 17 | T. Rowe Price ✦ | 49.91K | +5.5% | $2.39M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 18 | Wellington Management ✦ | 23.78K | +13.3% | $1.14M | 0.0% | ▲ Add | 6 | SEC ↗ ×4 |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Norges Bank | $989,886 | was 0.0% |
| Gotham Asset Management | $555,477 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 323 houders, 57.94M aandelen, $2.88B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.